NextCure Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
NextCure Inc
TickerNXTC
CIK #0001661059
CUSIP65343E207
SectorLife Sciences - Pharmaceutical Preparations
Address9000 Virginia Manor Road, Suite 200, Beltsville, MD 20705
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
NextCure Inc 2025-12-10 21.5 M Exemption: 506(b) · Duration: One year or less · Finder's Fee: $1,215,001 · Revenue: No Revenues
CIK Filing 2011 - 2026
[0001661059] 10-K
[0001661059] 10-Q
[0001661059] 3
[0001661059] 4
[0001661059] 8-K
[0001661059] D
[0001661059] SC 13D
[0001661059] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Ikarian Capital LLC NextCure Inc [2026-02-17] 0.0
SilverArc Capital Management LLC NextCure Inc [2026-02-12] 0.0
Squadron Capital Management LLC NextCure Inc [2025-10-24] 0.0
Simcere Zaiming Inc NextCure Inc [2025-08-19] 0.0
Citigroup Inc NextCure Inc [2025-05-12] 0.0
Affinity Asset Advisors LLC NextCure Inc [2024-06-27] 5.98
Logos Global Management LP NextCure Inc [2024-04-01] 7.2
Millennium Management LLC NextCure Inc [2023-01-24] 5.2
BlackRock Inc NextCure Inc [2021-02-02] 5.5
Morgan Stanley NextCure Inc [2020-10-26] 6.8
Great Point Partners LLC NextCure Inc [2020-02-21] 5.0
Lord Abbett & Co LLC NextCure Inc [2020-02-14] 5.38
Lilly Asia Ventures Fund III LP NextCure Inc [2020-02-13] 2.1
Canaan X LP NextCure Inc [2020-02-06] 8.2
Cormorant Asset Management LP NextCure Inc [2019-11-18] 4.95
Pfizer Inc NextCure Inc [2019-05-22] 8.7
OrbiMed Advisors LLC NextCure Inc [2019-05-21] 8.4
Sofinnova Venture Partners IX LP NextCure Inc [2019-05-17] 11.0
Citadel Advisors LLC NextCure Inc [2019-05-17] 4.9
Form 3/4/5 Filer 2011 - 2026
NextCure Inc
Kabakoff David S
Borgman Anne Elizabeth
Feigal Ellen
Webster Stephen W
Houston John G
Jones Elaine V
Guha Udayan
Richman Michael
Cobourn Steven P
Shaw Kevin G
Mayer Timothy
Kundu Sourav
Simcere Zaiming Inc
Langermann Sol
Myint Han
Nicholson Garry A
Khuong Chau Quang
Liu Linda
Xu Stella
Heller Kevin N
Li Judith
Morrison Briggs
Bingham James B
Sofinnova Management IX LLC
Sofinnova Venture Partners IX LP
Powell Michael
Mehra Anand
Healy James
Shannon Timothy M
Canaan Partners X LLC
Canaan X LP
OrbiMed Capital GP VI LLC
OrbiMed Advisors LLC
Alexandria Venture Investments LLC
Quan Venture Fund II LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Guha Udayan
Employee Stock Option (Right to Buy) · derivative
2026-01-30 Grant 14,670 $0.00
Shaw Kevin G
Employee Stock Option (Right to Buy) · derivative
2026-01-30 Grant 8,270 $0.00
Richman Michael
Employee Stock Option (Right to Buy) · derivative
2026-01-30 Grant 38,190 $0.00
Kundu Sourav
Employee Stock Option (Right to Buy) · derivative
2026-01-30 Grant 8,270 $0.00
Mayer Timothy
Employee Stock Option (Right to Buy) · derivative
2026-01-30 Grant 14,670 $0.00
Cobourn Steven P
Employee Stock Option (Right to Buy) · derivative
2026-01-30 Grant 14,670 $0.00
Borgman Anne Elizabeth
Stock Option (Right to Buy) · derivative
2025-06-20 Grant 18,700 $0.00
Houston John G
Stock Option (Right to Buy) · derivative
2025-06-20 Grant 18,700 $0.00
Jones Elaine V
Stock Option (Right to Buy) · derivative
2025-06-20 Grant 18,700 $0.00
Kabakoff David S
Stock Option (Right to Buy) · derivative
2025-06-20 Grant 28,050 $0.00
Webster Stephen W
Stock Option (Right to Buy) · derivative
2025-06-20 Grant 18,700 $0.00
Feigal Ellen
Stock Option (Right to Buy) · derivative
2025-06-20 Grant 18,700 $0.00
Shaw Kevin G
Employee Stock Option (Right to Buy) · derivative
2025-01-31 Grant 66,125 $0.00
Mayer Timothy
Employee Stock Option (Right to Buy) · derivative
2025-01-31 Grant 117,375 $0.00
Langermann Sol
Employee Stock Option (Right to Buy) · derivative
2025-01-31 Grant 117,375 $0.00
Kundu Sourav
Employee Stock Option (Right to Buy) · derivative
2025-01-31 Grant 66,125 $0.00
Cobourn Steven P
Employee Stock Option (Right to Buy) · derivative
2025-01-31 Grant 117,375 $0.00
Richman Michael
Employee Stock Option (Right to Buy) · derivative
2025-01-31 Grant 305,500 $0.00
Kabakoff David S
Stock Option (Right to Buy) · derivative
2024-06-20 Grant 28,050 $0.00
Webster Stephen W
Stock Option (Right to Buy) · derivative
2024-06-20 Grant 18,700 $0.00
showing 20 of 172 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 26 2,169,454
2025-12-31 24 1,897,561
2025-09-30 17 858,137
2025-06-30 32 10,547,686
2025-03-31 39 15,367,312
2024-12-31 47 16,035,434
2024-09-30 45 15,865,815
2024-06-30 50 18,512,232
2024-03-31 49 16,959,883
2023-12-31 44 13,424,734
2023-09-30 42 12,923,977
2023-06-30 44 13,367,521
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com